HUP0100012A2 - Use for macrolides for the treatment of cancer and macular degeneration - Google Patents

Use for macrolides for the treatment of cancer and macular degeneration

Info

Publication number
HUP0100012A2
HUP0100012A2 HU0100012A HUP0100012A HUP0100012A2 HU P0100012 A2 HUP0100012 A2 HU P0100012A2 HU 0100012 A HU0100012 A HU 0100012A HU P0100012 A HUP0100012 A HU P0100012A HU P0100012 A2 HUP0100012 A2 HU P0100012A2
Authority
HU
Hungary
Prior art keywords
treatment
macular degeneration
macrolides
cancer
amd
Prior art date
Application number
HU0100012A
Other languages
Hungarian (hu)
Inventor
Yat Sun Or
Jacob J. Plattner
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of HUP0100012A2 publication Critical patent/HUP0100012A2/en
Publication of HUP0100012A3 publication Critical patent/HUP0100012A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány daganatok és makuláris elváltozások kezelésére szolgálóeljárásra és gyógyszerkészítményekre vonatkozik. A kezelésre szorulóembernek vagy állatnak az (I), (II), (III), (IV), (V), (VI) és (VII)általános képletű vegyületek valamelyikének terápiásan hatékonymennyiségét adagolják. A korral járó degeneratív makuláriselváltozások (AMD) jelentik az idős emberek látásvesztésénekleggyakoribb okát. ÓThe invention relates to a method and pharmaceutical preparations for the treatment of tumors and macular lesions. A therapeutically effective amount of one of the compounds of general formula (I), (II), (III), (IV), (V), (VI) and (VII) is administered to a person or animal in need of treatment. Age-related macular degeneration (AMD) is the most common cause of vision loss in the elderly. HE

HU0100012A 1997-10-31 1998-10-30 Use for macrolides for the treatment of cancer and macular degeneration HUP0100012A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96147397A 1997-10-31 1997-10-31
PCT/US1998/023043 WO1999022722A2 (en) 1997-10-31 1998-10-30 Use of macrolides for the treatment of cancer and macular degeneration

Publications (2)

Publication Number Publication Date
HUP0100012A2 true HUP0100012A2 (en) 2001-05-28
HUP0100012A3 HUP0100012A3 (en) 2003-07-28

Family

ID=25504514

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100012A HUP0100012A3 (en) 1997-10-31 1998-10-30 Use for macrolides for the treatment of cancer and macular degeneration

Country Status (17)

Country Link
EP (1) EP1027060A2 (en)
JP (1) JP2001521891A (en)
KR (1) KR20010031577A (en)
CN (1) CN1278178A (en)
AR (1) AR043071A1 (en)
AU (1) AU1206799A (en)
BG (1) BG104436A (en)
BR (1) BR9813318A (en)
CA (1) CA2307850A1 (en)
HU (1) HUP0100012A3 (en)
IL (1) IL135518A0 (en)
NO (1) NO20002189L (en)
PL (1) PL340604A1 (en)
SK (1) SK6172000A3 (en)
TR (1) TR200001147T2 (en)
WO (1) WO1999022722A2 (en)
ZA (1) ZA989885B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001079520A1 (en) 2000-04-13 2001-10-25 Biotica Technology Limited Hybrid glycosylated products and their production and use
PT1539157E (en) 2002-09-18 2013-10-04 Univ Pennsylvania Rapamycin for use in inhibiting or preventing choroidal neovascularization
AR043050A1 (en) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
CA2520377A1 (en) 2003-03-28 2004-10-14 Cornell Research Foundation, Inc. Migrastatin analog compositions and uses thereof
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CN108101948A (en) * 2004-02-27 2018-06-01 瑞伯-X医药品有限公司 Macrocyclic compound and its making and use method
US8202843B2 (en) * 2004-02-27 2012-06-19 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
JP5149001B2 (en) 2004-05-25 2013-02-20 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ Migrastatin analogues in the treatment of cancer
EP1805161B1 (en) 2004-09-23 2014-05-07 Sloan-Kettering Institute For Cancer Research Isomigrastatin analogs in the treatment of cancer
ES2564194T3 (en) 2005-02-09 2016-03-18 Santen Pharmaceutical Co., Ltd. Liquid formulations for the treatment of diseases or ailments
PL1904056T3 (en) 2005-07-18 2009-09-30 Minu Llc Use of a macrolide to restore corneal sensation
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
ES2638427T3 (en) 2005-08-24 2017-10-20 Melinta Therapeutics, Inc. Triazole compounds and preparation and use procedures
BRPI0707612B8 (en) 2006-02-09 2021-05-25 Macusight Inc sealed vessel and liquid formulations contained therein
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
CN106317146B (en) * 2015-06-18 2019-06-21 沈阳药科大学 Bicyclic clarithomycin derivative and its as tumour cell increment inhibitor purposes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6461090A (en) * 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5498424A (en) * 1994-11-30 1996-03-12 Klein; Ira Method of treating obesity

Also Published As

Publication number Publication date
IL135518A0 (en) 2001-05-20
SK6172000A3 (en) 2001-03-12
PL340604A1 (en) 2001-02-12
NO20002189D0 (en) 2000-04-27
AR043071A1 (en) 2005-07-20
CN1278178A (en) 2000-12-27
WO1999022722A2 (en) 1999-05-14
BR9813318A (en) 2000-08-22
EP1027060A2 (en) 2000-08-16
HUP0100012A3 (en) 2003-07-28
TR200001147T2 (en) 2000-08-21
NO20002189L (en) 2000-06-28
KR20010031577A (en) 2001-04-16
ZA989885B (en) 1999-05-05
BG104436A (en) 2000-12-29
AU1206799A (en) 1999-05-24
JP2001521891A (en) 2001-11-13
CA2307850A1 (en) 1999-05-14
WO1999022722A3 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
HUP0100012A2 (en) Use for macrolides for the treatment of cancer and macular degeneration
HUP0105027A2 (en) Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds and their use
HUP0302114A2 (en) Liquis pharmaceutical composition comprising erythropoietin protein, method for its preparation and its use
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
MY124853A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives.
BR0311313A (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU2003240680A8 (en) 1h-imidazo(4,5-c) quinoline derivatives in the treatment of protein kinase dependent diseases
CA2186673A1 (en) The use of fatty acids in the treatment of huntington's chorea
BG101118A (en) Therapeutical compounds
RU92016244A (en) SUGARINE DERIVATIVES-INHIBITORS OF PROTEOLYTIC ENZYMES
NO910340L (en) TOPICAL PREPARATIONS FOR TREATMENT OF HUMAN Nails.
HUP0401903A2 (en) Improved use of et-743 in cancer thereapy
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
NZ304291A (en) Trisubstituted phenyl derivatives, preparation and pharmaceutical compositions thereof
EE03262B1 (en) Alkoxyalkylcarbamates from Imidazo [1,2-a] pyridines, their Preparation and Use
DK1039900T3 (en) Pharmaceutical preparation containing sibutramine and orlistat
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
CA2319542A1 (en) The treatment of sexual dysfunction in certain patient groups
BR0212249A (en) Compound, pharmaceutical composition, method of treatment or prophylaxis of diseases, and use of a compound
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
AU3862997A (en) Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
KR100488038B1 (en) New bpc peptide salts with organo-protective activity the process for their preparation and their use in therapy
ATE331523T1 (en) STATIN THERAPY TO IMPROVE MAINTAINING COGNITIVE FUNCTION
HUP0105469A2 (en) Therapeutic drugs comprising pyrroloazepines for treating intermittent claudication
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy